Safety and efficacy of anti-CD30 CAR-T cell therapy in relapsed/refractory classic Hodgkin lymphoma: a systematic review and meta-analysis

Safety and efficacy of anti-CD30 CAR-T cell therapy in relapsed/refractory classic Hodgkin lymphoma: a systematic review and meta-analysis

Abstract Background Relapsed/refractory classic Hodgkin lymphoma (R/R cHL) remains challenging to treat, and anti-CD30 chimeric antigen receptor T (CAR-T) cell therapy may be effective. This meta-analysis investigates the efficacy and safety of anti-CD30 CAR-T cell therapy for treating R/R cHL. Meth...

Full description

Saved in:
Bibliographic Details
Main Authors: Fanqiao Meng, Maoyuan Xiang, Yu Liu, Dongfeng Zeng
Format: Article
Language:English
Published: BMC 2025-01-01
Series:BMC Cancer
Subjects:
Hodgkin lymphoma
CD30
CAR-T
Systematic review
Online Access:https://doi.org/10.1186/s12885-024-13400-5
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items